Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XALNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBWNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAY.1.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.19NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GY.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBF.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GA.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAY.1.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.38NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CT.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.10.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FF.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.213NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.56 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.39.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.91.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.4.14 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.359NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.5.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.66NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.485NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CP.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.73NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.112.2 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Q.8 (Alpha)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.122.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.5.6 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.440NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.25NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.23.2 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.104 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.198NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAFNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BC.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.17.1 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.16NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.41NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.375NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BL.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AD.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.26.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.10.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAY.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CY.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used